China plans to be #1 in world pharmaceuticals--lower price, mimic foreign ops

Mundipharma worldwide hq:  

https://www.google.com/maps/uv?hl=en&pb=!1s0x47d871ab343538eb%3A0x17756e88d69012f4!3m1!7e115!4shttps%3A%2F%2Flh5.googleusercontent.com%2Fp%2FAF1QipPH0WOrsl0yjSFreHF8xyp8k-Vgu-m7f0bZWRvo%3Dw284-h160-k-no!5smundipharma%20cambridge%20uk%20-%20Google%20Search!15sCAQ&imagekey=!1e10!2sAF1QipMH7JuvgpHYxEoqEqInK1spqbUkPup3NK-4OAfC&sa=X&ved=2ahUKEwiE6JG-787mAhUZCjQIHRp9C9YQoiowKHoECCsQBg

Address: 194 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0AB, United Kingdom  Phone: +44 1223 424211   

....................................................................................................

Mundipharma in Pamplona, Spain:

............................................................

Mundipharma Singapore provides contact info for Mundipharma in 16 countries:  http://www.mundipharma.com.sg/about-us

.............................................................

Mundipharma China:   12 Dongdaqiao Rd, Guo Mao, Chaoyang, Beijing, China

Beijing Mengdi Pharmacy Limited

..............................................................................

Mundipharma Hong Kong:

mundipharma china address

..............................................................................

   China’s healthcare market is experiencing double-digit growth, but the relatively low healthcare spending as a portion of GDP in China (around 6% in China, compared to a range between 10% and 17% in the US, Europe and Japan) suggests that the market is still primed for further expansion....

  In pharmaceuticals specifically, China is comfortably the second-largest national market in the world, with healthcare analytics firm Iqvia putting its value at $122.6bn in 2017 and projecting growth to as much as $175bn by 2022, as reported by CNBC.  Multinational pharma firms are starting to make China a major priority for drug sales, as the potential for profit is now widely seen as a decisive counterbalance against the risks of operating under the Chinese regime....

  The government has insisted on significant price reductions for many drugs to consider their inclusion and reimbursement by state-funded insurance programmes, but many manufacturers are finding that lower prices are far outweighed by the volume of sales that comes from state reimbursement.   https://pharma.nridigital.com/pharma_dec18/is_china_the_next_great_hope_for_the_pharma_industry

.............................................................................................................

  an innovative drug might qualify for approval under the new Fast Track Drug Approval pathway. In general, drugs considered for approval via Fast Track must be truly innovative and address serious public health threats.  Of the six categories, there is only one fully objective criterion for meeting Fast Track qualification: foreign innovative drugs manufactured in China.  Coupled with this policy change is the ability for drug companies to engage the services of a contract manufacturing organization to bring approved innovative drugs to market, an option which did not previously exist.  http://paizabio.com/china-the-next-global-leader-in-the-pharmaceutical-industry/

......................................

The independent associated companies' facilities for manufacturing, packaging and logistics are found in the locations below and service worldwide markets. 

Canada (Purdue Frederick, Inc)
Cyprus (Mundipharma Pharmaceuticals Limited)
Germany (Mundipharma GmbH)
India (Modi Mundipharma Private Limited)
Israel (Rafa Laboratories Limited)
China (Mundipharma (China) Pharmaceutical Company Ltd)
UK (Bard Pharmaceuticals Limited)
USA (Purdue Pharmaceuticals LP and The PF Laboratories Inc)    https://www.mundipharma.net/manufacturing.html

................................................

  China is a major source of precursor chemicals necessary for the production of cocaine, heroin, MDMA and crystal methamphetamine, which are used by many Southeast Asian and Pacific Rim nations. China produces over 100,000 metric tons of acetic anhydride each year, and imports an additional 20,000 metric tons from the United States and Singapore. Reports indicate that acetic anhydride is diverted from China to morphine and heroin refineries in the Golden Triangle.^{[citation needed]} China is also a leading exporter of bulk ephedrine and has been a source country for much of the ephedrine and pseudoephedrine imported into Mexico; these precursor chemicals are subsequently used to manufacture methamphetamine destined for the United States. China is developing a significant MDMA production, trafficking, and consumption problem. Although China has taken actions through legislation and regulation of production and exportation of precursor chemicals, extensive action is required to control the illicit diversion and smuggling of precursor chemicals.

China not only continues to be a major transit route for Southeast Asian heroin bound for international drug markets, but also for Southwest Asian heroin entering northwestern China from Afghanistan, Pakistan, and Tajikistan.     A majority of the Southeast Asian heroin that enters China from Burma transits southern China to various international markets by maritime transport. Drug traffickers take advantage of expanding port facilities in coastal cities....

Many of the individuals involved in the international trafficking of Southeast Asian heroin are ethnic Kokang, Yunnanese, Fujianese, Cantonese, or members of other ethnic Chinese minority groups that reside outside of China. These groups reside, and are actively involved in drug trafficking in regions such as Burma, Cambodia, Canada, Hong Kong, Taiwan, Thailand, and the United States.

Reporting on the activities of drug trafficking organizations in China is sparse. However, Chinese officials report that drug traffickers are dividing their large shipments into smaller ones in order to minimize losses in case of seizure. Chinese officials also report that drug traffickers are increasingly using women, children, and poor, uneducated farmers to body-carry drugs from the Golden Triangle area to Guangdong and other provinces in China.  In China many individuals and criminal organizations involved in drug trafficking are increasingly arming themselves with automatic weapons and grenades to protect their drug shipments from theft by rival organizations....

China is of paramount importance in global cooperative efforts to prevent the diversion of precursor chemicals. With its large chemical industry, China remains a source country for legitimately produced chemicals that are diverted for production of heroin and cocaine, as well as many amphetamine-type stimulants. China and its neighbor India are the leading exporters of bulk ephedrine in the world. China produces over 100,000 metric tons of acetic anhydride each year, and imports an additional 20,000 metric tons from the United States and Singapore. China is also the second largest producer of potassium permanganate in the world....

The South China Morning Post reports the rise in the use of ketamine, easy to mass-produce in illicit labs in southern China, particularly among the young. Because of its low cost, and low profit margin, drug peddlers rely on mass distribution to make money, thus increasing its penetrative power to all, including schoolchildren.   https://en.wikipedia.org/wiki/Illegal_drug_trade_in_China